Medivation (Nasdaq: MDVN), the target of a hostile bid from French drug maker Sanofi (NYSE: SNY), has received a competing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE